IONIQ Sciences Inc (IONIQ), formerly Prolung Inc , is a medical device company that offers diagnostic services. The company provides electro pulmonary nodule scanner system used for the non invasive early diagnostics of different types of diseases. Its EPN system consists of scan monitor, scan keyboard, scan tower, scanners, scan kits and scanner probes. IONIQ's EPN system is based on bio-conductance technology similar to an EEG and EKG. The company's product is available for investigational use in the US. Its products are used in detection of lung cancer, and other diseases. IONIQ headquartered in Salt Lake City, Utah, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company IONIQ Sciences Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- IONIQ Sciences Inc Company Overview
- IONIQ Sciences Inc Company Snapshot
- IONIQ Sciences Inc Pipeline Products and Ongoing Clinical Trials Overview
- IONIQ Sciences Inc - Pipeline Analysis Overview
- IONIQ Sciences Inc - Key Facts
- IONIQ Sciences Inc - Major Products and Services
- IONIQ Sciences Inc Pipeline Products by Development Stage
- IONIQ Sciences Inc Ongoing Clinical Trials by Trial Status
- IONIQ Sciences Inc Pipeline Products Overview
- IONIQ Breast Test
- IONIQ Breast Test Product Overview
- IONIQ ProLung Test Kit
- IONIQ ProLung Test Kit Product Overview
- IONIQ System
- IONIQ System Product Overview
- IONIQ System Clinical Trial
- IONIQ Sciences Inc - Key Competitors
- IONIQ Sciences Inc - Key Employees
- IONIQ Sciences Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- IONIQ Sciences Inc, Recent Developments
- Oct 24, 2022: IONIQ Sciences to present at BioFuture
- Mar 17, 2022: IONIQ Sciencesc announces the addition of Edison Group as investor relations advisor
- Feb 13, 2020: ProLung Test granted ‘Breakthrough Device’ Designation by the FDA
- Nov 26, 2019: ProLung announces change to its board of directors
- Oct 31, 2019: ProLung, Inc. presents highest combined sensitivity and specificity values for a truly non-invasive lung cancer solution pursuing FDA clearance at ISRD & ATS joint medical conference
- Oct 31, 2019: Prolung presents highest combined sensitivity and specificity values for a truly non-invasive lung cancer solution pursuing FDA clearance At ISRD & ATS Joint Medical Conference
- Oct 03, 2019: ProLung announces large clinical validation trial results of 84% sensitivity and 74% specificity
- Oct 02, 2019: ProLung promotes Jared Bauer from interim CEO to CEO
- Aug 12, 2019: ProLung announces the appointment of Leavitt Partners and Mr. Rich McKeown to its Board of Directors
- Jun 12, 2019: ProLung announces changes to its board of directors and leadership team to enhance its Medtech expertise
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- IONIQ Sciences Inc Pipeline Products and Ongoing Clinical Trials Overview
- IONIQ Sciences Inc Pipeline Products by Equipment Type
- IONIQ Sciences Inc Pipeline Products by Indication
- IONIQ Sciences Inc Ongoing Clinical Trials by Trial Status
- IONIQ Sciences Inc, Key Facts
- IONIQ Sciences Inc, Major Products and Services
- IONIQ Sciences Inc Number of Pipeline Products by Development Stage
- IONIQ Sciences Inc Pipeline Products Summary by Development Stage
- IONIQ Sciences Inc Ongoing Clinical Trials by Trial Status
- IONIQ Sciences Inc Ongoing Clinical Trials Summary
- IONIQ Breast Test - Product Status
- IONIQ Breast Test - Product Description
- IONIQ ProLung Test Kit - Product Status
- IONIQ ProLung Test Kit - Product Description
- IONIQ System - Product Status
- IONIQ System - Product Description
- IONIQ System - Establish ProLung Test Measurement Collection Protocol for Future Studies: PL-210
- IONIQ Sciences Inc, Key Employees
- Glossary
- IONIQ Sciences Inc Pipeline Products by Equipment Type
- IONIQ Sciences Inc Pipeline Products by Development Stage
- IONIQ Sciences Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Chronix Biomedical Inc
- BioIQ Inc
- Oncimmune (USA) LLC
- A&G Pharmaceutical Inc
- BioCheck Inc
